Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 28, 2024

Oral Corticosteroid Dosage and Taper Duration at Onset Influence Time to First Relapse in Patients With MOGAD

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Neurology, Neurosurgery, and Psychiatry
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse
J. Neurol. Neurosurg. Psychiatr. 2024 May 16;[EPub Ahead of Print], BP Trewin, RC Dale, J Qiu, M Chu, N Jeyakumar, F Dela Cruz, J Andersen, P Siriratnam, KKM Ma, TA Hardy, A van der Walt, J Lechner-Scott, H Butzkueven, SA Broadley, MH Barnett, SW Reddel, F Brilot, T Kalincik, S Ramanathan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading